New Data Supports GlucoModicum's Needle-Free Glucose Monitor

 
• By Barnaby Pickering

The Helsinki-based start-up has released data demonstrating the efficacy of its magnetohydrodynamic technology and how it could be used to measure blood glucose levels.

A prototype version of GlucoModicum's Talisman device • Source: GlucoModicum

GlucoModicum, developers of a non-invasive method for measuring blood glucose, are touting new data that show glucose measurements taken with the company’s non-invasive magnetohydrodynamic (MHD) sampling technology correlate with capillary blood glucose samples.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diagnostics

More from Device Area